Achmea Investment Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,625
| Closed | -$192K | – | 592 |
|
|
2023
Q2 | $192K | Hold |
4,625
| – | – | ﹤0.01% | 532 |
|
|
2023
Q1 | $278K | Hold |
4,625
| – | – | 0.01% | 488 |
|
|
2022
Q4 | $318K | Hold |
4,625
| – | – | 0.01% | 522 |
|
|
2022
Q3 | $352K | Hold |
4,625
| – | – | 0.01% | 526 |
|
|
2022
Q2 | $321K | Hold |
4,625
| – | – | 0.01% | 520 |
|
|
2022
Q1 | $383K | Buy |
+4,625
| New | +$383K | 0.01% | 538 |
|
|
2021
Q4 | – | Sell |
-4,625
| Closed | -$538K | – | 475 |
|
|
2021
Q3 | $538K | Sell |
4,625
-293
| -6% | -$34.1K | 0.02% | 513 |
|
|
2021
Q2 | $1.09M | Buy |
4,918
+465
| +10% | +$103K | 0.04% | 399 |
|
|
2021
Q1 | $589K | Hold |
4,453
| – | – | 0.02% | 483 |
|
|
2020
Q4 | $771K | Buy |
+4,453
| New | +$771K | 0.03% | 427 |
|